These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21949845)

  • 21. BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF.
    Link KA; Burd CJ; Williams E; Marshall T; Rosson G; Henry E; Weissman B; Knudsen KE
    Mol Cell Biol; 2005 Mar; 25(6):2200-15. PubMed ID: 15743818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
    Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
    Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
    Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
    Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells.
    Hsiao PW; Chang C
    J Biol Chem; 1999 Aug; 274(32):22373-9. PubMed ID: 10428808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells.
    Buchanan G; Need EF; Barrett JM; Bianco-Miotto T; Thompson VC; Butler LM; Marshall VR; Tilley WD; Coetzee GA
    Mol Cell Endocrinol; 2011 Aug; 342(1-2):20-31. PubMed ID: 21664238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.
    Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E
    Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
    Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW
    Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of androgen receptor transactivation by the SWI3-related gene product (SRG3) in multiple ways.
    Hong CY; Suh JH; Kim K; Gong EY; Jeon SH; Ko M; Seong RH; Kwon HB; Lee K
    Mol Cell Biol; 2005 Jun; 25(12):4841-52. PubMed ID: 15923603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP.
    Sato N; Sadar MD; Bruchovsky N; Saatcioglu F; Rennie PS; Sato S; Lange PH; Gleave ME
    J Biol Chem; 1997 Jul; 272(28):17485-94. PubMed ID: 9211894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural and functional consequences of glutamine tract variation in the androgen receptor.
    Buchanan G; Yang M; Cheong A; Harris JM; Irvine RA; Lambert PF; Moore NL; Raynor M; Neufing PJ; Coetzee GA; Tilley WD
    Hum Mol Genet; 2004 Aug; 13(16):1677-92. PubMed ID: 15198988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer.
    Yeh S; Sampson ER; Lee DK; Kim E; Hsu CL; Chen YL; Chang HC; Altuwaijri S; Huang KE; Chang C
    J Formos Med Assoc; 2000 Dec; 99(12):885-94. PubMed ID: 11155740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domains.
    Tavassoli P; Wafa LA; Cheng H; Zoubeidi A; Fazli L; Gleave M; Snoek R; Rennie PS
    Mol Endocrinol; 2010 Apr; 24(4):696-708. PubMed ID: 20181722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The chicken ovalbumin upstream promoter-transcription factor II negatively regulates the transactivation of androgen receptor in prostate cancer cells.
    Song CH; Lee HJ; Park E; Lee K
    PLoS One; 2012; 7(11):e49026. PubMed ID: 23145053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
    Cherian MT; Wilson EM; Shapiro DJ
    J Biol Chem; 2012 Jul; 287(28):23368-80. PubMed ID: 22589544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction.
    Suh JH; Shong M; Choi HS; Lee K
    Mol Endocrinol; 2008 Jan; 22(1):33-46. PubMed ID: 17885209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
    Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
    Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.
    Chattopadhyay S; Gong EY; Hwang M; Park E; Lee HJ; Hong CY; Choi HS; Cheong JH; Kwon HB; Lee K
    Mol Endocrinol; 2006 May; 20(5):984-95. PubMed ID: 16455820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of androgen receptor transactivation function by adenovirus type 12 E1A undermines prostate cancer cell survival.
    Li D; Tian G; Wang J; Zhao LY; Co O; Underill ZC; Mymryk JS; Claessens F; Dehm SM; Daaka Y; Liao D
    Prostate; 2018 Nov; 78(15):1140-1156. PubMed ID: 30009471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
    Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C
    J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.